TipRanks
Go Ultimate55% OFF

Kromek Group plc (KMK) AI Stock Analysis

GB:KMK

Kromek Group plc

(LSE:KMK)

Select Model
Rating:52Neutral
Price Target:GBX 5.50â–¼(-1.79% Downside)
Action:reiterated
Date:09/15/26

The overall score of 52 reflects an early-stage but fragile financial turnaround supported by a solid, low-debt balance sheet, offset by weakening recent earnings quality and volatile cash generation, while the technical picture is clearly negative with the price trading below all major moving averages and showing bearish momentum, and a rich valuation with no dividend further constrains the upside relative to the risks.

Positive Factors
Return to profitabilityThe return to profitability establishes a stronger earnings base than in prior loss-making years. Although recent margins weakened, sustained positive earnings can support internal funding, improve resilience, and provide a platform for rebuilding operating performance over the next several quarters.
Negative Factors
Revenue contractionA 28.3% revenue decline signals weakened demand, delivery timing, or customer activity and reduces the scale over which fixed costs can be absorbed. If the contraction persists, it could limit investment capacity, weaken market momentum, and delay a durable recovery in earnings.

Kromek Group plc (KMK) vs. iShares MSCI United Kingdom ETF (EWC)

-40%-20%0%20%40%60%80%GB:KMK-26.35%EWC+24.02%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
GBP 35.71M
Dividend Yield
―
Average Volume (3M)
1.45M
Price to Earnings (P/E)
49.5
Beta (1Y)
1.02
Revenue Growth
2.30%
EPS Growth
-81.36%
Country
UK
Employees
166
Sector
Technology
Sector Strength
61
Industry
Hardware, Equipment & Parts

Kromek Group plc Business Overview & Revenue Model

Company Description

Kromek Group plc, a UK-based entity established in 2013 with headquarters in Sedgefield, specializes in the design, production, and global distribution of advanced radiation detection components and devices. These technologies provide high-resolution...

How the Company Makes Money

Kromek makes money primarily by selling radiation detection products and related technology to commercial and government customers. Key revenue streams include: (1) Product sales of radiation detector components and systems: Kromek supplies detector...

Kromek Group plc Financial Statement Overview

Summary

Financials show a move from losses and cash burn to modest profitability and positive cash flow, backed by a conservatively leveraged, equity-rich balance sheet, but the latest year features weaker growth, margin compression, sharply lower returns on capital, and a steep drop in cash generation, indicating an early and fragile turnaround.

Income Statement

57Neutral

Balance Sheet

74Positive

Cash Flow

45Neutral
Financial statement breakdown
BreakdownTTMApr 2025Apr 2024Apr 2023Apr 2022Apr 2021
Income Statement
Total Revenue27.11M27.11M26.51M19.40M17.31M12.05M
Gross Profit14.00M14.00M21.43M10.71M6.04M3.07M
EBITDA7.00M7.00M9.30M2.93M-1.25M-1.23M
Net Income733.00K733.00K3.75M-3.29M-6.10M-4.92M
Balance Sheet
Total Assets70.27M70.27M65.87M70.19M63.88M67.42M
Cash, Cash Equivalents and Short-Term Investments4.16M4.16M1.70M466.00K1.10M5.08M
Total Debt9.36M9.36M4.05M12.29M13.38M11.00M
Total Liabilities15.84M15.84M13.69M20.84M22.35M19.99M
Stockholders Equity54.43M54.43M52.18M49.35M41.52M47.44M
Cash Flow
Free Cash Flow2.67M2.67M15.71M-7.84M-5.78M-10.29M
Operating Cash Flow3.00M3.00M15.90M-2.80M-504.00K-3.84M
Investing Cash Flow-4.94M-4.94M-4.55M-5.00M-5.27M-6.45M
Financing Cash Flow4.56M4.56M-9.19M7.18M1.99M-1.23M

Kromek Group plc Technical Analysis

Technical Analysis SentimentNegative
Last Price5.60

Price Trends

50DMA6.50Negative
100DMA7.38Negative
200DMA8.86Negative

Market Momentum

MACD-0.28Negative
RSI35.46Neutral
STOCH31.55Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:KMK, the sentiment is Negative. The current price of 5.60 is below the 20-day moving average (MA) of 5.65, below the 50-day MA of 6.50, and below the 200-day MA of 8.86, indicating a bearish trend. The MACD of -0.28 indicates Negative momentum. The RSI at 35.46 is Neutral, neither overbought nor oversold. The STOCH value of 31.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:KMK.

Kromek Group plc Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

GB:KMK against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GB:DSCVGB:DSCV69NeutralGBP 793.96M27.539.04%1.57%4.82%17.80%
GB:TTGGB:TTG63NeutralGBP 347.99M-9.73-24.38%―-2.68%47.33%
Sector *61Neutral$37.18B12.37-10.20%1.83%8.50%-7.62%
GB:JDGGB:JDG54NeutralGBP 226.46M-377.78-0.72%3.48%-8.18%-105.44%
GB:KMKGB:KMK52NeutralGBP 35.71M49.551.32%―2.30%-81.36%
GB:WPHOGB:WPHO39UnderperformGBP 8.47M-1.18-68.21%―-29.53%-210.26%

* Technology Sector Average

Performance Comparison

-50%0%50%GB:KMKGB:JDGGB:TTGGB:WPHOGB:DSCVDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
GB:KMK and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
GB:KMKKromek Group plc5.45-1.35-19.85%
GB:JDGJudges Scientific3430.00-1992.72-36.75%
GB:TTGTT Electronics187.2037.6025.13%
GB:WPHOWindar Photonics4.10-53.40-92.87%
GB:DSCVDiscoverie Group836.00269.3547.53%

Kromek Group plc Corporate Events

Business Operations and StrategyExecutive/Board ChangesPrivate Placements and FinancingShareholder Meetings

Kromek bolsters board and expands HSBC credit line ahead of AGM

Positive
Oct 2, 2026

Kromek Group plc has called its Annual General Meeting for 23 October 2026 at its NETPark headquarters and has released its annual report and accounts for the year ended 30 April 2026 to shareholders and via its investor relations website. The compan...

Business Operations and StrategyFinancial Disclosures

Kromek to Host Investor Q&A Following Release of 2026 Final Results

Positive
Sep 16, 2026

Kromek Group plc has invited investors to an online Q&A webinar with CEO Arnab Basu and CFO Claire Burgess on 21 September 2026, following the publication of its final results for the year ended 30 April 2026. A pre-recorded results presentation...

Business Operations and Strategy

Kromek Chairman Increases Stake with Share Purchase

Positive
Sep 15, 2026

Kromek Group plc has disclosed that its non-executive chairman, Rakesh Sharma, purchased 145,454 ordinary shares at 6.88p each on 15 September 2026. Following this transaction, Sharma and his wife now hold 1,729,167 shares, representing around 0.3% o...

Other

Kromek Chairman’s Family Boosts Stake With Share Purchase

Positive
Sep 14, 2026

Kromek Group plc reported that Kathleen Sharma, wife of Non-executive Chairman Rakesh Sharma, acquired 144,092 ordinary shares at 6.94 pence apiece on 14 September 2026. Following the transaction, Mr. Sharma’s total interest, including his wife...

Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing

Kromek boosts underlying imaging growth and secures key security contracts in FY 2026

Positive
Sep 14, 2026

Kromek Group plc, a specialist in advanced imaging and CBRN detection technologies, reported modest revenue growth to £27.1m for the year to 30 April 2026, driven by a strong underlying performance in Advanced Imaging and rising demand in CBRN D...

Business Operations and StrategyExecutive/Board ChangesFinancial Disclosures

Kromek hits third Siemens milestone and awards executives new share options

Positive
Aug 6, 2026

Kromek Group plc, a global detection specialist listed on AIM, develops radiation and bio-detection solutions for advanced medical imaging, security and industrial applications, as well as CBRN detection systems for defence and homeland security mark...

Other

Kromek Chairman Rakesh Sharma Increases Stake with Share Purchase

Positive
Aug 3, 2026

Kromek Group plc has disclosed that its non‑executive chairman, Rakesh Sharma, purchased 129,413 ordinary shares at 7.57p per share on 31 July, increasing his holding to 1,439,621 shares, or about 0.2% of the company’s issued share capita...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 15, 2026